Cargando…

The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation

BACKGROUND: ALDOA plays an essential role in cancer progression in different human cancers; however, its function has not been understood in prostate cancer (PCa). METHODS: Associations of ALDOA expression with clinicopathological features and patient prognosis in PCa were evaluated based on data ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuang, Qiwen, Liang, Yuxiang, Zhuo, Yangjia, Cai, Zhiduan, Jiang, Funeng, Xie, Jianjiang, Zheng, Yu, Zhong, Weide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163754/ https://www.ncbi.nlm.nih.gov/pubmed/34079281 http://dx.doi.org/10.2147/OTT.S290284

Ejemplares similares

Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
por: Chen, Chaojiang, et al.
Publicado: (2020)

Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer
por: Cai, Zhiduan, et al.
Publicado: (2020)

Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer
por: Ye, Jianheng, et al.
Publicado: (2023)

Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer
por: Dong, Weimin, et al.
Publicado: (2020)

Down-regulation of ACACA suppresses the malignant progression of Prostate Cancer through inhibiting mitochondrial potential
por: Zhang, Hui, et al.
Publicado: (2021)

A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism
por: Liu, Ren, et al.
Publicado: (2021)

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
por: Jia, Zhenyu, et al.
Publicado: (2019)

Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer
por: Zou, Zhihao, et al.
Publicado: (2021)

Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer
por: Han, Zhaodong, et al.
Publicado: (2022)

LncRNA ZNF674-AS1 regulates granulosa cell glycolysis and proliferation by interacting with ALDOA
por: Li, Duan, et al.
Publicado: (2021)

Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity
por: Lin, Jinguan, et al.
Publicado: (2022)

MiR-122 Promotes the Development of Colon Cancer by Targeting ALDOA In Vitro
por: Li, Hong, et al.
Publicado: (2019)

Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer
por: Han, Zhaodong, et al.
Publicado: (2022)

Disulfiram‐copper activates chloride currents and induces apoptosis with tyrosine kinase in prostate cancer cells
por: Lei, Wei, et al.
Publicado: (2021)

Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells
por: Ge, Rongbin, et al.
Publicado: (2015)

Acetyl-CoA carboxylase 1 depletion suppresses de novo fatty acid synthesis and mitochondrial β-oxidation in castration-resistant prostate cancer cells
por: Liu, Shaoyou, et al.
Publicado: (2022)

High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer
por: Dai, Ling, et al.
Publicado: (2018)

Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies
por: Tan, Xiao, et al.
Publicado: (2023)

ALDOA inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway in pancreatic cancer cells
por: Chen, Haidi, et al.
Publicado: (2021)

Blockade of PGK1 and ALDOA enhances bilirubin control of Th17 cells in Crohn’s disease
por: Vuerich, Marta, et al.
Publicado: (2022)

TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis
por: Zhu, Xuejin, et al.
Publicado: (2021)

Corrigendum: TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis
por: Zhu, Xuejin, et al.
Publicado: (2021)

Long noncoding RNA DIO3OS interacts with miR-122 to promote proliferation and invasion of pancreatic cancer cells through upregulating ALDOA
por: Cui, Kang, et al.
Publicado: (2019)

Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer
por: Zeng, Jie, et al.
Publicado: (2023)

Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction
por: Wang, Hao, et al.
Publicado: (2021)

The glycolytic enzyme ALDOA and the exon junction complex protein RBM8A are regulators of ribosomal biogenesis
por: Schwarz, Jessica Denise, et al.
Publicado: (2022)

Upregulated miR‑378a‑3p expression suppresses energy metabolism and promotes apoptosis by targeting a GLUT‑1/ALDOA/PKM2 axis in esophageal carcinoma
por: Qu, Yuan, et al.
Publicado: (2023)

Macrosphelide A Exhibits a Specific Anti-Cancer Effect by Simultaneously Inactivating ENO1, ALDOA, and FH
por: Song, Kyoung, et al.
Publicado: (2021)

A novel lncRNA ARST represses glioma progression by inhibiting ALDOA-mediated actin cytoskeleton integrity
por: Sun, Jun, et al.
Publicado: (2021)

Erratum: The glycolytic enzyme ALDOA and the exon junction complex protein RBM8A are regulators of ribosomal biogenesis
por: Frontiers Production Office,
Publicado: (2022)

LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability
por: Han, Lijie, et al.
Publicado: (2023)

Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer
por: Ye, Jianheng, et al.
Publicado: (2018)

NONHSAG028908.3 sponges miR‑34a‑5p to promote growth of colorectal cancer via targeting ALDOA
por: Wang, Chuanzhuo, et al.
Publicado: (2023)

Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer
por: Zhang, Yanqiong, et al.
Publicado: (2018)

MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis
por: Wang, Jun, et al.
Publicado: (2022)

Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation
por: Jiang, Min-Yao, et al.
Publicado: (2017)

Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumors
por: Zhang, Fan, et al.
Publicado: (2017)

The fructose-bisphosphate, Aldolase A (ALDOA), facilitates DNA-PKcs and ATM kinase activity to regulate DNA double-strand break repair
por: Sobanski, Thais, et al.
Publicado: (2023)

Association between allergic conditions and risk of prostate cancer: A Prisma-Compliant Systematic Review and Meta-Analysis
por: Zhu, Jianguo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l5fqff32bf2000vvq7qi827lko